MedTrace Logo

Controlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia

NCT02466659 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2017-11-30

Study results available
· View outcomes & findings →

Summary

To determine the effectiveness of alternate occlusion therapy for the treatment of IXT among patients aged 3 to \< 11 years old.

Conditions

  • Intermittent Exotropia

Interventions

DEVICE

CIAO therapy Amblyz glasses

3-hour CIAO Therapy Amblyz glasses

Sponsors & Collaborators

  • Indiana University School of Medicine

    lead OTHER

Principal Investigators

  • Daniel E Neely, MD · Glick Eye Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-01
Primary Completion
2016-12-01
Completion
2016-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02466659 on ClinicalTrials.gov